Apnimed is a privately held, clinical-stage pharmaceutical company based in Cambridge, Massachusetts, dedicated to transforming the treatment landscape for sleep-related breathing diseases. We believe the introduction of simple, once-nightly oral drugs may dramatically expand diagnosis and the reach of treatment for people with OSA. OSA, like other common chronic diseases such as diabetes or hypertension, would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment, and help more people get the oxygen and restorative sleep needed to thrive.

Apnimed is advancing a robust pipeline of oral pharmaceutical product candidates designed to improve oxygenation in individuals living with OSA and other chronic sleep-related breathing diseases. Our lead candidate, AD109, could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. Apnimed is also developing several therapies as part of its joint venture with Shionogi & Co., Ltd., Shionogi-Apnimed Sleep Science. Learn more at apnimed.com or follow us on X and LinkedIn.

Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder and excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit the Company’s website.

Established in 2010, Saatva is the original DTC mattress industry disruptor, founded on the principle that everyone deserves healthy and restorative sleep on a quality bed. As the pioneer of the online luxury mattress category, Saatva delivers premium sleep products with high-touch service, including free in-room delivery and old mattress removal. Saatva’s collection includes innerspring, organic natural latex, high density memory foam, and adjustable mattresses designed in collaboration with orthopedic and sleep health experts. As the brand of choice for thousands of medical professionals, Saatva is committed to supporting clinical outcomes and elevating sleep standards through education and evidence-backed product design. Visit our website for more information.

Transforming CardioSLEEP Solutions at Home!

VirtuOx, Inc. is a global digital health company that provides diagnostic tools and services that enable a variety of healthcare organizations and professionals diagnose cardiac, sleep and respiratory diseases through vertically integrated platforms, products and services.